Skip to main content

Lunai Bioworks Inc.

LNAI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001527728

No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Lunai Bioworks Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of LNAI: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders4139−2
Shares7.25M14.2M+6.92M (+95.5%)
Value$19.2M$24.8M+$5.58M (+29.0%)

New holders (17)

Institutions that held Lunai Bioworks Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to LNAI in Q2 2024
InstitutionSharesValue% of portfolio
Charles Schwab Investment Management Inc198,966$348.2K0.00%
Bank of New York Mellon Corp125,461$219.6K0.00%
New York State Common Retirement Fund66,700$116.7K0.00%
Nuveen Asset Management, LLC66,288$116.0K0.00%
Alpine Global Management, LLC46,782$81.9K0.01%
Rhumbline Advisers45,197$79.1K0.00%
Alliancebernstein L.P.37,890$66.3K0.00%
Corebridge Financial, Inc.26,232$46.2K0.00%
Invesco Ltd.22,996$40.2K0.00%
Two Sigma Securities, LLC16,804$29.4K0.00%
Barclays PLC16,727$29.3K0.00%
Simplex Trading, LLC5,492$9.00K0.00%
Legal & General Group Plc4,977$8.68K0.00%
Ameritas Investment Partners, Inc.4,777$8.36K0.00%
California State Teachers Retirement System3,533$6.18K0.00%
Amalgamated Bank1,687$3.00K0.00%
Price T Rowe Associates Inc15,945$00.00%

Sold out (19)

Institutions that held Lunai Bioworks Inc. at the end of Q1 2024 and filed for Q2 2024 without it.